Læknablaðið : fylgirit - 01.05.1978, Qupperneq 31

Læknablaðið : fylgirit - 01.05.1978, Qupperneq 31
Heinola Study Group, 18120 Heinola 12, Finland RHEUMATOID FACTOR AND THE PROGRESSION OF INF LAMMATORY ARTHRITIS The purpose of this study was to evaluate the importance of different clinical and laboratory parameters in predicting the prognosis of the joint disease at its early stage. The progress of the disease was measured by funetional disability and joint swelling scores after one follow-up. The patient material included 279 arthritis patients. The studied parameters were measured not more than six months from the appearing of the first symptoms. The parameters used are shown in table 1. The material was devided into three groups according to the progress of the disease during one year. Both functional disability and joint swelling groups were used (table 2 and 3). In comparisons between these groups differences of means were used. R esults: Differences between functional disability groups showed that age had the greatest differentiating power (table 4). The prognostic value of clinical measurements (morning stiffness, joint tender- ness, joint swelling) was also highly significant, while of the laboratory parameters only ESR and Waaler-Rose had significant differentiating power. Table 5 shows that when material was divided into three groups according to joint swelling the differentiating power of parameters increased. The clinical status scores again had the best prognostic value, age had lost but ESB and rheumatoid factor, especiaUy Latex, had increased their significance. Antinuclear antibodies and complement factors had the least importance in this context. When the statistical analysis (table 6) was computed separately with RA-patients, the group with the worst prognosis differed significantly from milder cases (groups 1 and 2). The best predictors now were Latex-titre and number of swoUen joints. When the functional disabUity groups were used in multiple discriminant analysis, age increased most the discriminating power. After that came joint tenderness, C4, morning stiffness and Latex. Discussion: The predicting of the prognosis of inflammatory joint disease at the early stage is very important for the planning of rehabUitation and care of the patient. Low complement level and high rheuma- toid fact titre have been considered sign of poor prognosis in RA. This material however consists of different arthritis cases, and earlier results cannot be compared with the results of this study. The measuring of the prognosis of the disease can be done by functional disabUity, joint involve- ment, radiological changes, activity of the inflammation and deteriorating in social status and changes in psychological reactions. In this study only functional disability and joint swelling were used as a criterion for prognosis. Of these the functional disabUity had a highly signifi- cant correlation with the age (p < 0.001) and therefore makes the results invalid in this respect. Correlation between the age and the joint swelling was not significant and therefore joint sweUing is a better sign for the prognosis. In conclusion it can be said that clinical para- meters, especially the duration of morning stiff- ness and the number of swollen joints predict best the prognosis of the joint disease after one year. Of the laboratoiy tests, ESR and rheuma- toid factor have the greatest predicting value. Table 1 Age •pOTD VARIABLES S-muco S-CRP S-IgG S-IgA S-Waaler-Rose S-Latex-titre S-Latex S-Antinuclear antibodies S-C 3 S-C 4 S-E 1 -inhibitor Morning stiffness Joint tenderness Joint swelling Punctional disability 29 I___________________________________
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.